Skip to content

Form 4 filed by Kumar Neil

Kumar Neil filed this Form 4 on BBIO (BridgeBio Pharma, Inc.) with 6 transaction rows and 2 holding rows, accepted by EDGAR 2026-11-20 21:33:18 UTC.

Accession
0001743881-26-000045
Filed
2026-11-20
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: BBIO · BridgeBio Pharma, Inc. (CIK 1743881)

  • Kumar Neil director, officer (Chief Executive Officer)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-18S sold-4,490$76.9916273,817D
Common Stock 2026-11-18S sold-30,490$77.8271243,327D
Common Stock 2026-11-18S sold-1,277$76.9915494,409I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Common Stock 2026-11-18S sold-8,723$77.8269485,686I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Common Stock 2026-11-19S sold-8,500$78.3503477,186I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Common Stock 2026-11-19S sold-1,500$79.293475,686I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Common Stock holding 750,000I By NK 2026 GRAT
Common Stock holding 3,568,447I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.